Diagnostics

  • Scientists working in Laboratory for visual analyze the sample in petri dish.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Thermo Fisher closes $1.1B sale of microbiology unit to PE firm

    European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.

    By • Aug. 13, 2026
  • A Grail employee in white coat and blue gloves works with a blood sample.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    FDA sets advisory panel for Galleri multicancer screening test

    Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.

    By • Aug. 7, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A portrait of Danaher CEO Julie Sawyer Montgomery.
    Image attribution tooltip
    Permission granted by Danaher
    Image attribution tooltip

    Danaher promotes Julie Sawyer Montgomery to CEO

    The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw the recent acquisition of Masimo.

    By • Aug. 4, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers names new head of the Americas

    The company disclosed the appointment of João Seabra the day before cutting its full-year sales outlook in response to continued challenges at its diagnostics division.

    By • Aug. 3, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers, Cleveland Clinic form 10-year alliance

    The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.

    By • July 31, 2026
  • A Freenome employee wearing a white coat and purple gloves is shown working in a laboratory.
    Image attribution tooltip
    Permission granted by Freenome
    Image attribution tooltip

    Freenome secures FDA nod for blood-based colorectal cancer test

    Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will compete with Guardant Health’s Shield blood test for colorectal cancer screening.

    By • July 27, 2026
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE HealthCare inks 10-year, $500M alliance with Catholic Health

    The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and UC San Diego.

    By • July 21, 2026
  • A person wearing a blue glove holds a test tube with red liquid
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Tempus to buy cancer test maker Personalis for $1.5B

    Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

    By • July 20, 2026
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Exact Sciences/Business Wire
    Image attribution tooltip

    Abbott reports diagnostics growth since $21B Exact Sciences buy

    The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.

    By • July 16, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip
    Q&A

    Abbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’

    Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.

    By • July 15, 2026
  • An illustration of pain in the colon.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Freenome colorectal cancer test data improve on earlier results

    The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.

    By • July 13, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Top 10 medtech deals in the first half of 2026

    Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.

    By • July 6, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant’s Shield colon cancer blood test snags UnitedHealth coverage

    One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.

    By • July 2, 2026
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent finalizes Biocare Medical takeover

    The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.

    By • June 26, 2026
  • Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Labcorp rolls out colorectal cancer screening test nationwide

    The Geneoscopy test competes with Exact Sciences’ Cologuard for the U.S. colorectal cancer screening market.

    By • June 25, 2026
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Danaher closes $9.9B Masimo buyout

    CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.

    By • June 11, 2026
  • An image of Olympus executive Keith Boettiger seated at a table.
    Image attribution tooltip
    Permission granted by Olympus
    Image attribution tooltip
    Q&A

    Olympus’ Keith Boettiger on robotic GI surgery push

    Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.

    By • June 5, 2026
  • A Grail employee in white coat and blue gloves works with a blood sample.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    At ASCO, Grail points to positive signals in MCED data

    Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.

    By • June 2, 2026
  • 23andMe
    Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    California attorney general sues over 23andMe data breach

    The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.

    By • May 29, 2026
  • A headshot of Solomon Moshkevich
    Image attribution tooltip
    Permission granted by Natera
    Image attribution tooltip
    Q&A

    Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence

    Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.

    By • May 29, 2026
  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Guardant wins FDA approval for updated liquid biopsy

    The company could secure a higher price for the new test than for its older, narrower product, Wall Street analysts said.

    By • May 21, 2026
  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Natera wins FDA approval for companion diagnostic

    The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.

    By • May 18, 2026
  • Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Labcorp expands Epic pact to make full test menu available on Aura

    The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies including Quest Diagnostics.

    By • May 14, 2026
  • A modern office building at the Roche Diagnostics campus features a sleek glass façade with the Roche logo displayed near the entrance, and the structure is surrounded by landscaped greenery.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Roche to acquire digital pathology firm PathAI for up to $1.05B

    Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.

    By • May 7, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Top medtech executive moves in 2026

    Medtronic created a new position, while Illumina built out its C-suite and DePuy Synthes named its CFO ahead of a split with J&J. Read MedTech Dive’s roundup for all the details.

    By MedTech Dive Staff • Updated July 13, 2026